首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer genetics

缩写:CANCER GENET-NY

ISSN:2210-7762

e-ISSN:2210-7770

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1103
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ana Valeria Silva Alencar,Giulianna Aparecida Vieira Barreto,Maria Cláudia Dos Santos Luciano et al. Ana Valeria Silva Alencar et al.
To analyze the influence of Lynch Syndrome on the incidence of adverse reactions to antineoplastic treatment in patients with colorectal cancer. Observational and retrospective study based on analyzing electronic medical records of patients...
Katsuhiro Masago,Eiichi Sasaki,Yasuko Fujita et al. Katsuhiro Masago et al.
Background: High-grade serous ovarian carcinoma (HGSOC) accounts for 70% of all ovarian cancer cases and 80% of related deaths. TP53 mutations are common; however, other driving genetic factors are not well understood. In...
Aarthi Goverdhan,Lisa Mullineaux,Amber Pryzbylski et al. Aarthi Goverdhan et al.
Accurate clinical interpretation of somatic cancer variants is critical for diagnosis and guidance of precision oncology treatment. As the depth and breadth of genomic sequencing increased, laboratories developed independent standards for t...
Jun Zhang,Yang Xu,Xiao Han et al. Jun Zhang et al.
Galectin-9 plays multiple roles in various tumors and exerts immune regulation within the tumor microenvironment. It is closely associated with tumor prognosis. This study aimed to analyze the expression of galectin-9 in the colon tumor mic...
Wanfang Yang,Jing Xu,Shuhua Cao et al. Wanfang Yang et al.
Mutations in Isocitrate Dehydrogenase-1 (IDH1) and IDH2 lead to abnormal histone hypermethylation and DNA modifications, disrupting cell differentiation, yet the clinical and prognostic significance of these mutations in primary acute myelo...
Yifan Wei,Haiyang Guo,Jingjie Zhou et al. Yifan Wei et al.
The transcription factor ZHX2 exerts paradoxical roles in cancer, acting as either an oncogene or tumor suppressor in a context-dependent manner. This duality stems from ZHX2's regulation of key processes including cell cycle, apoptosis, EM...
Xiaojuan Zhang,Juan Xie,Tao Fu et al. Xiaojuan Zhang et al.
Laminin, a critical component of the basement membrane, plays an indispensable role in numerous biological processes. Among its subunits, laminin γ2 (LAMC2) emerges as a key player in the progression of cancer. This review delves into the ...
Kirankumar Nalla,Biji Chatterjee,Jagadeesha Poyya et al. Kirankumar Nalla et al.
Background: Dysregulation of epigenetic processes, characterized by aberrant DNA methylation patterns and histone modifications, is a hallmark of cancer, driving its initiation, progression, and metastasis by silencing tu...
Tetsuko Kobayashi,Satsuki Matsushima,Hiroaki Ohnishi Tetsuko Kobayashi
MYC proto-oncogene may be amplified ectopically in acute myeloid leukemia (AML) as extrachromosomal DNA (ecDNA) such as double minutes (dmins). However, the mechanism and location of MYC amplification have not been fully elucidated. To char...
Junxu Chen,Dongwook Kim,Jae Young Kim et al. Junxu Chen et al.
Background: Oral squamous cell carcinoma (OSCC) carries substantial mortality despite surgery-based management. Reliable biomarkers and practical prognostic tools are needed to guide individualized care. ...